Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Hoffmann

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Cellular and Molecular Medicine|January 16, 2025
Antagonisation of Prokineticin Receptor-2 Attenuates Preeclampsia SymptomsFrédéric Sergent, Daniel Vaiman, Tiphaine Raia-Barjat, et al.
Cancers|July 2, 2021
NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive MicroenvironmentDeborah Reynaud, Roland Abi Nahed, Nicolas Lemaitre, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 10, 2017
Antenatal prognostic factor of fetal echogenic bowelCandice Ronin, Pierre Mace, Fabien Stenard, et al.
Environment International|February 22, 2025
PFAS exposure during pregnancy: Implications for placental health and functioningSadia Khan, Marion Ouidir, Nicolas Lemaitre, et al.
Biology of Reproduction|July 6, 2019
Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesisNadia Alfaidy, Chloé Baron, Yannick Antoine, et al.
BMJ Open|November 20, 2024
IROND-L: study protocol for a French prospective, quasi-experimental, multicentre trial to examine the impact of a coordinated multidisciplinary approach for women victims of violenceFabienne El-Khoury, Inès Ben Ghezala, Ghada Hatem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression <i>In Vitro</i> and <i>In Vivo</i>Wael Traboulsi, Frédéric Sergent, Houssine Boufettal, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Cellular and Molecular Medicine|January 16, 2025
Antagonisation of Prokineticin Receptor-2 Attenuates Preeclampsia SymptomsFrédéric Sergent, Daniel Vaiman, Tiphaine Raia-Barjat, et al.
Cancers|July 2, 2021
NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive MicroenvironmentDeborah Reynaud, Roland Abi Nahed, Nicolas Lemaitre, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 10, 2017
Antenatal prognostic factor of fetal echogenic bowelCandice Ronin, Pierre Mace, Fabien Stenard, et al.
Environment International|February 22, 2025
PFAS exposure during pregnancy: Implications for placental health and functioningSadia Khan, Marion Ouidir, Nicolas Lemaitre, et al.
Biology of Reproduction|July 6, 2019
Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesisNadia Alfaidy, Chloé Baron, Yannick Antoine, et al.
BMJ Open|November 20, 2024
IROND-L: study protocol for a French prospective, quasi-experimental, multicentre trial to examine the impact of a coordinated multidisciplinary approach for women victims of violenceFabienne El-Khoury, Inès Ben Ghezala, Ghada Hatem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression <i>In Vitro</i> and <i>In Vivo</i>Wael Traboulsi, Frédéric Sergent, Houssine Boufettal, et al.
Pageof 5